Mostrar el registro sencillo del ítem
Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (ESTAHEP clinical trial)
| dc.contributor.author | Riaño, Ioana | |
| dc.contributor.author | Martín, Leticia | |
| dc.contributor.author | Varela Calvo, María | |
| dc.contributor.author | Serrano, Trinidad | |
| dc.contributor.author | Núñez, Óscar | |
| dc.contributor.author | Mínguez, Beatriz | |
| dc.contributor.author | Rodrigues, Pedro M. | |
| dc.contributor.author | Perugorria, María J. | |
| dc.contributor.author | Banales, Jesús M. | |
| dc.contributor.author | Arenas, Juan I. | |
| dc.date.accessioned | 2021-01-27T10:20:17Z | |
| dc.date.available | 2021-01-27T10:20:17Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Cancers, 12(7) (2020); doi:10.3390/cancers12071900 | |
| dc.identifier.issn | 2072-6694 | |
| dc.identifier.uri | http://hdl.handle.net/10651/57607 | |
| dc.description.sponsorship | This study was funded by the Spanish “Ministerio de Sanidad, Servicios sociales e Igualdad” through the call for “Ayudas para el fomento de la investigación clínica independiente” (project EC10-201). J.M.B. was funded by the Spanish Carlos III Health Institute (ISCIII) (FIS PI15/01132, PI18/01075 and Miguel Servet Program CON14/00129 and CPII19/00008) co-financed by “Fondo Europeo de Desarrollo Regional” (FEDER), AMMF, Euskadi RIS3 (2019222054), and “Fundación Científica de la Asociación Española Contra el Cáncer” (AECC Scientific Foundation: “Rare cancers grant 2017”). | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cancers | |
| dc.rights | © 2020 los autores | |
| dc.rights | CC Reconocimiento 4.0 Internacional | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087800795&doi=10.3390%2fcancers12071900&partnerID=40&md5=7f0362ebc06b224ee741268b3ee3aa55 | |
| dc.title | Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (ESTAHEP clinical trial) | |
| dc.type | journal article | |
| dc.identifier.doi | 10.3390/cancers12071900 | |
| dc.relation.projectID | EC10-201 | |
| dc.relation.projectID | FIS PI15/01132 | |
| dc.relation.projectID | PI18/01075 | |
| dc.relation.projectID | CON14/00129 | |
| dc.relation.projectID | CPII19/00008 | |
| dc.relation.publisherversion | http://dx.doi.org/10.3390/cancers12071900 | |
| dc.rights.accessRights | open access | |
| dc.type.hasVersion | VoR |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [34667]
-
Investigaciones y Documentos OpenAIRE [7580]
Publicaciones resultado de proyectos financiados con fondos públicos -
Medicina [897]
Este ítem está sujeto a una licencia Creative Commons